Ion Beam Applications (OTCMKTS:IOBCF) Stock Price Up 1.5% – Should You Buy?
by Scott Moore · The Cerbat GemIon Beam Applications SA (OTCMKTS:IOBCF – Get Free Report)’s stock price rose 1.5% during trading on Thursday . The company traded as high as $17.35 and last traded at $17.35. Approximately 170 shares changed hands during trading, a decline of 70% from the average daily volume of 567 shares. The stock had previously closed at $17.10.
Ion Beam Applications Trading Up 3.9%
The business’s fifty day moving average price is $16.42 and its 200 day moving average price is $16.09.
About Ion Beam Applications
Ion Beam Applications (OTCMKTS: IOBCF) is a Belgium-based medical technology company specializing in the development and deployment of particle therapy solutions for cancer treatment. Founded in 1986 and headquartered in Louvain-la-Neuve, the company is best known for its Proteus® line of proton therapy systems, which are designed to deliver precise, high-energy particle beams that target tumors while sparing healthy tissue. IBA oversees the full project lifecycle, from system design and manufacturing to installation, commissioning, and ongoing service support.
In addition to its flagship proton therapy business, IBA operates a diversified portfolio of technologies for medical and industrial applications.